{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T07:38:44Z","timestamp":1792741124173,"version":"4.5.0"},"reference-count":70,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,7,18]],"date-time":"2023-07-18T00:00:00Z","timestamp":1689638400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,7,18]],"date-time":"2023-07-18T00:00:00Z","timestamp":1689638400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Reprod Biol Endocrinol"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Assisted reproductive technology (ART) has brought good news to infertile patients, but how to improve the pregnancy outcome of poor ovarian response (POR) patients is still a serious challenge and the scientific evidence of some adjuvant therapies remains controversial.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Aim<\/jats:title>\n                <jats:p>Based on previous evidence, the purpose of this systematic review and network meta-analysis was to evaluate the effects of DHEA, CoQ10, GH and TEAS on pregnancy outcomes in POR patients undergoing in vitro fertilization and embryo transplantation (IVF-ET). In addition, we aimed to determine the current optimal adjuvant treatment strategies for POR.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>PubMed, Embase, The Cochrane Library and four databases in China (CNKI, Wanfang, VIP, SinoMed) were systematically searched up to July 30, 2022, with no restrictions on language. We included randomized controlled trials (RCTs) of adjuvant treatment strategies (DHEA, CoQ10, GH and TEAS) before IVF-ET to improve pregnancy outcomes in POR patients, while the control group received a controlled ovarian stimulation (COS) regimen only. This study was reported in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA). The surface under the cumulative ranking curve (SUCRA) was used to provide a pooled measure of cumulative ranking for each outcome.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Sixteen RCTs (2323 women) with POR defined using the Bologna criteria were included in the network meta-analysis. Compared with the control group, CoQ10 (OR 2.22, 95% CI: 1.05 to 4.71) and DHEA (OR 1.92, 95% CI: 1.16 to 3.16) had obvious advantages in improving the clinical pregnancy rate. CoQ10 was the best in improving the live birth rate (OR 2.36, 95% CI: 1.07 to 5.38). DHEA increased the embryo implantation rate (OR 2.80, 95%CI: 1.41 to 5.57) and the high-quality embryo rate (OR 2.01, 95% CI: 1.07 to 3.78) and number of oocytes retrieved (WMD 1.63, 95% CI: 0.34 to 2.92) showed a greater advantage, with GH in second place. Several adjuvant treatment strategies had no significant effect on reducing the cycle canceling rate compared with the control group. TEAS was the least effective of the four adjuvant treatments in most pooled results, but the overall effect appeared to be better than that of the control group.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>Compared with COS regimen, the adjuvant use of CoQ10, DHEA and GH before IVF may have a better clinical effect on the pregnancy outcome of POR patients. TEAS needs careful consideration in improving the clinical pregnancy rate. Future large-scale RCTs with direct comparisons are needed to validate or update this conclusion.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Systematic review registration<\/jats:title>\n                <jats:p>PROSPERO CRD42022304723<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12958-023-01119-0","type":"journal-article","created":{"date-parts":[[2023,7,18]],"date-time":"2023-07-18T13:02:19Z","timestamp":1689685339000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["TEAS, DHEA, CoQ10, and GH for poor ovarian response undergoing IVF-ET: a systematic review and network meta-analysis"],"prefix":"10.1186","volume":"21","author":[{"given":"Fengya","family":"Zhu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shao","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siyun","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xia","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianyu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deya","family":"Che","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,7,18]]},"reference":[{"issue":"5","key":"1119_CR1","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.1016\/j.fertnstert.2014.07.740","volume":"102","author":"F Simonstein","year":"2014","unstructured":"Simonstein F, Mashiach-Eizenberg M, Revel A, Younis JS. Assisted reproduction policies in Israel: a retrospective analysis of in vitro fertilization-embryo transfer. Fertil Steril. 2014;102(5):1301\u20136. https:\/\/doi.org\/10.1016\/j.fertnstert.2014.07.740","journal-title":"Fertil Steril"},{"issue":"2","key":"1119_CR2","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1093\/humrep\/dev319","volume":"31","author":"MS Kupka","year":"2016","unstructured":"Kupka MS, D\u2019Hooghe T, Ferraretti AP, de Mouzon J, Erb K, Castilla JA, et al. Assisted reproductive technology in Europe, 2011: results generated from European registers by ESHRE. Hum Reprod. 2016;31(2):233\u201348. https:\/\/doi.org\/10.1093\/humrep\/dev319","journal-title":"Hum Reprod"},{"issue":"9","key":"1119_CR3","doi-asserted-by":"publisher","first-page":"1586","DOI":"10.1093\/humrep\/dey242","volume":"33","author":"C De Geyter","year":"2018","unstructured":"De Geyter C, Calhaz-Jorge C, Kupka MS, Wyns C, Mocanu E, Motrenko T, et al. ART in Europe, 2014: results generated from european registries by ESHRE: the european IVF-monitoring Consortium (EIM) for the European Society of Human Reproduction and Embryology (ESHRE). Hum Reprod. 2018;33(9):1586\u2013601. https:\/\/doi.org\/10.1093\/humrep\/dey242","journal-title":"Hum Reprod"},{"issue":"1","key":"1119_CR4","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1007\/bf01131588","volume":"8","author":"Z Ben-Rafael","year":"1991","unstructured":"Ben-Rafael Z, Bider D, Dan U, Zolti M, Levran D, Mashiach S. Combined gonadotropin releasing hormone agonist\/human menopausal gonadotropin therapy (GnRH-a\/hMG) in normal, high, and poor responders to hMG. J In Vitro Fert Embryo Transf. 1991;8(1):33\u20136. https:\/\/doi.org\/10.1007\/bf01131588","journal-title":"J In Vitro Fert Embryo Transf"},{"issue":"7","key":"1119_CR5","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1093\/oxfordjournals.humrep.a137459","volume":"6","author":"JM Jenkins","year":"1991","unstructured":"Jenkins JM, Davies DW, Devonport H, Anthony FW, Gadd SC, Watson RH, et al. Comparison of \u2018poor\u2019 responders with \u2018good\u2019 responders using a standard buserelin\/human menopausal gonadotrophin regime for in-vitro fertilization. Hum Reprod. 1991;6(7):918\u201321. https:\/\/doi.org\/10.1093\/oxfordjournals.humrep.a137459","journal-title":"Hum Reprod"},{"issue":"4","key":"1119_CR6","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1016\/s0015-0282(99)00630-5","volume":"73","author":"ES Surrey","year":"2000","unstructured":"Surrey ES, Schoolcraft WB. Evaluating strategies for improving ovarian response of the poor responder undergoing assisted reproductive techniques. Fertil Steril. 2000;73(4):667\u201376. https:\/\/doi.org\/10.1016\/s0015-0282(99)00630-5","journal-title":"Fertil Steril"},{"issue":"6","key":"1119_CR7","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1093\/humupd\/dmp026","volume":"15","author":"EM Kolibianakis","year":"2009","unstructured":"Kolibianakis EM, Venetis CA, Diedrich K, Tarlatzis BC, Griesinger G. Addition of growth hormone to gonadotrophins in ovarian stimulation of poor responders treated by in-vitro fertilization: a systematic review and meta-analysis. Hum Reprod Update. 2009;15(6):613\u201322. https:\/\/doi.org\/10.1093\/humupd\/dmp026","journal-title":"Hum Reprod Update"},{"issue":"3","key":"1119_CR8","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1093\/humupd\/dmw001","volume":"22","author":"A Papathanasiou","year":"2016","unstructured":"Papathanasiou A, Searle BJ, King NM, Bhattacharya S. Trends in \u2018poor responder\u2019 research: lessons learned from RCTs in assisted conception. Hum Reprod Update. 2016;22(3):306\u201319. https:\/\/doi.org\/10.1093\/humupd\/dmw001","journal-title":"Hum Reprod Update"},{"key":"1119_CR9","doi-asserted-by":"publisher","first-page":"642","DOI":"10.3389\/fendo.2019.00642","volume":"10","author":"Y Li","year":"2019","unstructured":"Li Y, Li X, Yang X, Cai S, Lu G, Lin G, et al. Cumulative live birth rates in low prognosis patients according to the POSEIDON Criteria: an analysis of 26,697 cycles of in vitro Fertilization\/Intracytoplasmic sperm injection. Front Endocrinol (Lausanne). 2019;10:642. https:\/\/doi.org\/10.3389\/fendo.2019.00642","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"5","key":"1119_CR10","doi-asserted-by":"publisher","first-page":"1058","DOI":"10.1016\/j.fertnstert.2011.09.048","volume":"96","author":"NP Polyzos","year":"2011","unstructured":"Polyzos NP, Devroey P. A systematic review of randomized trials for the treatment of poor ovarian responders: is there any light at the end of the tunnel? Fertil Steril. 2011;96(5):1058\u201361. https:\/\/doi.org\/10.1016\/j.fertnstert.2011.09.048","journal-title":"Fertil Steril"},{"issue":"7","key":"1119_CR11","doi-asserted-by":"publisher","first-page":"1616","DOI":"10.1093\/humrep\/der092","volume":"26","author":"AP Ferraretti","year":"2011","unstructured":"Ferraretti AP, La Marca A, Fauser BC, Tarlatzis B, Nargund G, Gianaroli L. ESHRE consensus on the definition of \u2018poor response\u2019 to ovarian stimulation for in vitro fertilization: the Bologna criteria. Hum Reprod. 2011;26(7):1616\u201324. https:\/\/doi.org\/10.1093\/humrep\/der092","journal-title":"Hum Reprod"},{"key":"1119_CR12","doi-asserted-by":"publisher","first-page":"352098","DOI":"10.1155\/2014\/352098","volume":"2014","author":"F Ubaldi","year":"2014","unstructured":"Ubaldi F, Vaiarelli A, D\u2019Anna R, Rienzi L. Management of poor responders in IVF: is there anything new? Biomed Res Int. 2014;2014:352098. https:\/\/doi.org\/10.1155\/2014\/352098","journal-title":"Biomed Res Int"},{"issue":"2","key":"1119_CR13","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1016\/j.fertnstert.2009.03.027","volume":"94","author":"M Berkkanoglu","year":"2010","unstructured":"Berkkanoglu M, Ozgur K. What is the optimum maximal gonadotropin dosage used in microdose flare-up cycles in poor responders? Fertil Steril. 2010;94(2):662\u20135. https:\/\/doi.org\/10.1016\/j.fertnstert.2009.03.027","journal-title":"Fertil Steril"},{"issue":"3","key":"1119_CR14","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1016\/j.fertnstert.2007.12.077","volume":"91","author":"D Kyrou","year":"2009","unstructured":"Kyrou D, Kolibianakis EM, Venetis CA, Papanikolaou EG, Bontis J, Tarlatzis BC. How to improve the probability of pregnancy in poor responders undergoing in vitro fertilization: a systematic review and meta-analysis. Fertil Steril. 2009;91(3):749\u201366. https:\/\/doi.org\/10.1016\/j.fertnstert.2007.12.077","journal-title":"Fertil Steril"},{"issue":"12","key":"1119_CR15","doi-asserted-by":"publisher","first-page":"3481","DOI":"10.1093\/humrep\/des318","volume":"27","author":"NP Polyzos","year":"2012","unstructured":"Polyzos NP, Blockeel C, Verpoest W, De Vos M, Stoop D, Vloeberghs V, et al. Live birth rates following natural cycle IVF in women with poor ovarian response according to the Bologna criteria. Hum Reprod. 2012;27(12):3481\u20136. https:\/\/doi.org\/10.1093\/humrep\/des318","journal-title":"Hum Reprod"},{"issue":"6","key":"1119_CR16","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1016\/j.rbmo.2011.01.015","volume":"22","author":"SK Sunkara","year":"2011","unstructured":"Sunkara SK, Pundir J, Khalaf Y. Effect of androgen supplementation or modulation on ovarian stimulation outcome in poor responders: a meta-analysis. Reprod Biomed Online. 2011;22(6):545\u201355. https:\/\/doi.org\/10.1016\/j.rbmo.2011.01.015","journal-title":"Reprod Biomed Online"},{"key":"1119_CR17","doi-asserted-by":"publisher","unstructured":"Gleicher N, Barad DH. Dehydroepiandrosterone (DHEA) supplementation in diminished ovarian reserve (DOR). Reprod Biol Endocrinol. 2011;9:67. https:\/\/doi.org\/10.1186\/1477-7827-9-67","DOI":"10.1186\/1477-7827-9-67"},{"key":"1119_CR18","doi-asserted-by":"publisher","first-page":"f2914","DOI":"10.1136\/bmj.f2914","volume":"346","author":"EJ Mills","year":"2013","unstructured":"Mills EJ, Thorlund K, Ioannidis JP. Demystifying trial networks and network meta-analysis. BMJ. 2013;346:f2914. https:\/\/doi.org\/10.1136\/bmj.f2914","journal-title":"BMJ"},{"issue":"2","key":"1119_CR19","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1002\/jrsm.1037","volume":"3","author":"G Salanti","year":"2012","unstructured":"Salanti G. Indirect and mixed-treatment comparison, network, or multiple-treatments meta-analysis: many names, many benefits, many concerns for the next generation evidence synthesis tool. Res Synth Methods. 2012;3(2):80\u201397. https:\/\/doi.org\/10.1002\/jrsm.1037","journal-title":"Res Synth Methods"},{"issue":"2","key":"1119_CR20","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1093\/humupd\/dmz046","volume":"26","author":"Y Zhang","year":"2020","unstructured":"Zhang Y, Zhang C, Shu J, Guo J, Chang HM, Leung PCK, et al. Adjuvant treatment strategies in ovarian stimulation for poor responders undergoing IVF: a systematic review and network meta-analysis. Hum Reprod Update. 2020;26(2):247\u201363. https:\/\/doi.org\/10.1093\/humupd\/dmz046","journal-title":"Hum Reprod Update"},{"issue":"5","key":"1119_CR21","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1016\/j.tjog.2017.08.017","volume":"56","author":"YC Hsu","year":"2017","unstructured":"Hsu YC, Liang IT, Huang SY, Wang HS, Soong YK, Chang CL. Transcutaneous electrical acupoint stimulation (TEAS) treatment improves pregnancy rate and implantation rate in patients with implantation failure. Taiwan J Obstet Gynecol. 2017;56(5):672\u20136. https:\/\/doi.org\/10.1016\/j.tjog.2017.08.017","journal-title":"Taiwan J Obstet Gynecol"},{"key":"1119_CR22","doi-asserted-by":"publisher","unstructured":"Szmit M, Agrawal S, Go\u017adzik W et al. Transcutaneous Electrical Acupoint Stimulation Reduces Postoperative Analgesic Requirement in Patients Undergoing Inguinal Hernia Repair: A Randomized, Placebo-Controlled Study. J Clin Med. 2021;10(1). https:\/\/doi.org\/10.3390\/jcm10010146","DOI":"10.3390\/jcm10010146"},{"issue":"3","key":"1119_CR23","doi-asserted-by":"publisher","first-page":"e1003583","DOI":"10.1371\/journal.pmed.1003583","volume":"18","author":"MJ Page","year":"2021","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. PLoS Med. 2021;18(3):e1003583. https:\/\/doi.org\/10.1371\/journal.pmed.1003583","journal-title":"PLoS Med"},{"issue":"10","key":"1119_CR24","doi-asserted-by":"publisher","first-page":"2075","DOI":"10.1093\/humrep\/deu218","volume":"29","author":"RS Legro","year":"2014","unstructured":"Legro RS, Wu X, Barnhart KT, Farquhar C, Fauser BC, Mol B. Improving the reporting of clinical trials of infertility treatments (IMPRINT): modifying the CONSORT statement\u2020\u2021. Hum Reprod. 2014;29(10):2075\u201382. https:\/\/doi.org\/10.1093\/humrep\/deu218","journal-title":"Hum Reprod"},{"issue":"6","key":"1119_CR25","doi-asserted-by":"publisher","first-page":"458","DOI":"10.3969\/j.issn.1674-1889.2018.06.004","volume":"37","author":"Rong","year":"2018","unstructured":"Rong, Hu, Brand New Qu. Effect of dehydroepiandrosterone on ovarian responsiveness and in vitro fertilization-embryo transfer outcomes in patients with low ovarian responsiveness. Int J Reproductive Health\/Family Plann. 2018;37(6):458\u201362. https:\/\/doi.org\/10.3969\/j.issn.1674-1889.2018.06.004. (in Chinese).","journal-title":"Int J Reproductive Health\/Family Plann"},{"key":"1119_CR26","unstructured":"Li X. Effect of growth hormone on embryo quality and pregnancy outcome in patients with low ovarian response with IVF-ET. Yangzhou University. 2018, MA thesis. https:\/\/kns.cnki.net\/KCMS\/detail\/detail.aspx?dbname=CMFD201901&filename=1018089597.nh"},{"issue":"2","key":"1119_CR27","first-page":"110","volume":"25","author":"PI Cai-rong Liao","year":"2017","unstructured":"Cai-rong Liao PI, Jie ZHU, Jing-xiang LI, Xiao-qing. Effect of dehydroepiandrosterone combined with antagonist regimen in vitro fertilization-embryo transfer. Chin J Eugenics and Genetics. 2017;25(2):110\u20131.","journal-title":"Chin J Eugenics and Genetics"},{"issue":"08","key":"1119_CR28","first-page":"622","volume":"24","author":"Wu Hui Song","year":"2015","unstructured":"Hui Song Wu, Yan TIAN, Guo-hua LI, Wei YS, Yan-hong HUANG. Effect of dehydroepiandrosterone pretreatment on in vitro fertilization-embryo transfer outcomes in patients with low ovarian response. J Reprod Med. 2015;24(08):622\u20135.","journal-title":"J Reprod Med"},{"issue":"15","key":"1119_CR29","first-page":"49","volume":"23","author":"Y Tang","year":"2013","unstructured":"Tang Y, Guangxiu ZHongLu, Fei G. Application of growth hormone in patients with low ovarian response. Chin J Mod Med. 2013;23(15):49\u201353.","journal-title":"Chin J Mod Med"},{"key":"1119_CR30","doi-asserted-by":"publisher","unstructured":"Wu X-Y, Zhan-Hong TAN, Bei-mei LIU, Chen Ru-jia, Lin Xiao-ping, Jian-Feng XIAO. Effect of antagonist regimen plus GH on endometrial receptivity and pregnancy outcome in POR patients. Chinese Journal of Sex Science (2018) 27(8):79\u201383. (in Chinese) https:\/\/doi.org\/10.3969\/j.issn.1672-1993.2018.08.024","DOI":"10.3969\/j.issn.1672-1993.2018.08.024"},{"issue":"1","key":"1119_CR31","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/s12958-018-0343-0","volume":"16","author":"Y Xu","year":"2018","unstructured":"Xu Y, Nisenblat V, Lu C, Li R, Qiao J, Zhen X, et al. Pretreatment with coenzyme Q10 improves ovarian response and embryo quality in low-prognosis young women with decreased ovarian reserve: a randomized controlled trial. Reprod Biol Endocrinol. 2018;16(1):29. https:\/\/doi.org\/10.1186\/s12958-018-0343-0","journal-title":"Reprod Biol Endocrinol"},{"issue":"7","key":"1119_CR32","doi-asserted-by":"publisher","first-page":"2033","DOI":"10.31557\/APJCP.2019.20.7.2033","volume":"20","author":"L Safdarian","year":"2019","unstructured":"Safdarian L, Aghahosseini M, Alyasin A, Samaei Nouroozi A, Rashidi S, Shabani Nashtaei M, et al. Growth hormone (GH) improvement of ovarian responses and pregnancy outcome in poor ovarian responders: a randomized study. Asian Pac J Cancer Prev. 2019;20(7):2033\u20137.","journal-title":"Asian Pac J Cancer Prev"},{"issue":"1","key":"1119_CR33","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1186\/s12958-020-00648-2","volume":"18","author":"Y Gong","year":"2020","unstructured":"Gong Y, Zhang K, Xiong D, Wei J, Tan H, Qin S. Growth hormone alleviates oxidative stress and improves the IVF outcomes of poor ovarian responders: a randomized controlled trial. Reprod Biol Endocrinol. 2020;18(1):91. https:\/\/doi.org\/10.1186\/s12958-020-00648-2","journal-title":"Reprod Biol Endocrinol"},{"key":"1119_CR34","unstructured":"Mi H. Clinical study on the effect of transcutaneous electrical acupoint stimulation on pregnancy outcome of IVF-ET in infertile patients with low ovarian response. Shandong University of Traditional Chinese Medicine. 2018, MA thesis. https:\/\/kns.cnki.net\/KCMS\/detail\/detail.aspx?dbname=CMFD201501&filename=1015506882.nh"},{"issue":"5","key":"1119_CR35","doi-asserted-by":"publisher","first-page":"522","DOI":"10.7661\/j.cjim.20170315.032","volume":"37","author":"F Lian","year":"2017","unstructured":"Lian F. Clinical study of percutaneous electrical acupoint stimulation combined with luminal physiotherapy in the treatment of renal deficiency type ovarian hyporesponsiveness. Chin J Integr Traditional Western Med. 2017;37(5):522\u20135. https:\/\/doi.org\/10.7661\/j.cjim.20170315.032","journal-title":"Chin J Integr Traditional Western Med"},{"issue":"3","key":"1119_CR36","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1016\/j.fertnstert.2015.11.026","volume":"105","author":"YA Bassiouny","year":"2016","unstructured":"Bassiouny YA, Dakhly DMR, Bayoumi YA, Hashish NM. Does the addition of growth hormone to the in vitro fertilization\/intracytoplasmic sperm injection antagonist protocol improve outcomes in poor responders? A randomized, controlled trial. Fertil Steril. 2016;105(3):697\u2013702.","journal-title":"Fertil Steril"},{"issue":"7","key":"1119_CR37","doi-asserted-by":"publisher","first-page":"1030","DOI":"10.1111\/1471-0528.17045","volume":"129","author":"Z Wang","year":"2022","unstructured":"Wang Z, Yang A, Bao H, Wang A, Deng X, Xue D, et al. Effect of dehydroepiandrosterone administration before in vitro fertilization on the live birth rate in poor ovarian responders according to the Bologna criteria: a randomised controlled trial. BJOG. 2022;129(7):1030\u20138. https:\/\/doi.org\/10.1111\/1471-0528.17045","journal-title":"BJOG"},{"key":"1119_CR38","doi-asserted-by":"publisher","unstructured":"Kotb MM, Hassan AM, AwadAllah AM. Does dehydroepiandrosterone improve pregnancy rate in women undergoing IVF\/ICSI with expected poor ovarian response according to the Bologna criteria? A randomized controlled trial. Eur J Obstet Gynecol Reprod Biol. 2016;200:11https:\/\/doi.org\/10.1016\/j.ejogrb.2016.02.009","DOI":"10.1016\/j.ejogrb.2016.02.009"},{"issue":"3","key":"1119_CR39","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1007\/s00404-017-4613-4","volume":"297","author":"SA Choe","year":"2018","unstructured":"Choe SA, Kim MJ, Lee HJ, Kim J, Chang EM, Kim JW, et al. Increased proportion of mature oocytes with sustained-release growth hormone treatment in poor responders: a prospective randomized controlled study. Arch Gynecol Obstet. 2018;297(3):791\u20136. https:\/\/doi.org\/10.1007\/s00404-017-4613-4","journal-title":"Arch Gynecol Obstet"},{"issue":"1","key":"1119_CR40","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.tjog.2020.10.003","volume":"60","author":"EH Mohammad","year":"2021","unstructured":"Mohammad EH, Abou El Serour AG, Mohamed EAH, Abbasy AH, Zaatar M, Rageh KA, et al. Efficacy of growth hormone supplementation with ultrashort GnRH antagonist in IVF\/ICSI for poor responders; randomized controlled trial. Taiwan J Obstet Gynecol. 2021;60(1):51\u20135. https:\/\/doi.org\/10.1016\/j.tjog.2020.10.003","journal-title":"Taiwan J Obstet Gynecol"},{"key":"1119_CR41","doi-asserted-by":"publisher","unstructured":"Showell MG, Mackenzie-Proctor R, Jordan V, Hart RJ. Antioxidants for female subfertility. 2017;7(7):Cd007807. https:\/\/doi.org\/10.1002\/14651858.CD007807.pub3","DOI":"10.1002\/14651858.CD007807.pub3"},{"issue":"10","key":"1119_CR42","doi-asserted-by":"publisher","first-page":"2377","DOI":"10.1007\/s10815-020-01906-3","volume":"37","author":"P Florou","year":"2020","unstructured":"Florou P, Anagnostis P, Theocharis P, Chourdakis M, Goulis DG. Does coenzyme Q(10) supplementation improve fertility outcomes in women undergoing assisted reproductive technology procedures? A systematic review and meta-analysis of randomized-controlled trials. J Assist Reprod Genet. 2020;37(10):2377\u201387. https:\/\/doi.org\/10.1007\/s10815-020-01906-3","journal-title":"J Assist Reprod Genet"},{"issue":"4","key":"1119_CR43","doi-asserted-by":"publisher","first-page":"369","DOI":"10.5935\/1518-0557.20180046","volume":"22","author":"JE Schwarze","year":"2018","unstructured":"Schwarze JE, Canales J, Crosby J, Ortega-Hrepich C, Villa S, Pommer R. DHEA use to improve likelihood of IVF\/ICSI success in patients with diminished ovarian reserve: a systematic review and meta-analysis. JBRA Assist Reprod. 2018;22(4):369\u201374. https:\/\/doi.org\/10.5935\/1518-0557.20180046","journal-title":"JBRA Assist Reprod"},{"issue":"3","key":"1119_CR44","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1016\/j.ijgo.2015.06.028","volume":"131","author":"J Li","year":"2015","unstructured":"Li J, Yuan H, Chen Y, Wu H, Wu H, Li L. A meta-analysis of dehydroepiandrosterone supplementation among women with diminished ovarian reserve undergoing in vitro fertilization or intracytoplasmic sperm injection. Int J Gynaecol Obstet. 2015;131(3):240\u20135.","journal-title":"Int J Gynaecol Obstet"},{"issue":"8","key":"1119_CR45","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1007\/s10815-016-0713-5","volume":"33","author":"M Zhang","year":"2016","unstructured":"Zhang M, Niu W, Wang Y, Xu J, Bao X, Wang L, et al. Dehydroepiandrosterone treatment in women with poor ovarian response undergoing IVF or ICSI: a systematic review and meta-analysis. J Assist Reprod Genet. 2016;33(8):981\u201391.","journal-title":"J Assist Reprod Genet"},{"issue":"7","key":"1119_CR46","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1055\/a-0882-3791","volume":"79","author":"L Xu","year":"2019","unstructured":"Xu L, Hu C, Liu Q, Li Y. The Effect of Dehydroepiandrosterone (DHEA) supplementation on IVF or ICSI: a Meta-analysis of Randomized controlled trials. Geburtshilfe Frauenheilkd. 2019;79(7):705\u201312. https:\/\/doi.org\/10.1055\/a-0882-3791","journal-title":"Geburtshilfe Frauenheilkd"},{"key":"1119_CR47","doi-asserted-by":"publisher","unstructured":"Nagels HE, Rishworth JR, Siristatidis CS, Kroon B. Androgens (dehydroepiandrosterone or testosterone) for women undergoing assisted reproduction. Cochrane Database Syst Rev. 2015;11:Cd009749. https:\/\/doi.org\/10.1002\/14651858.CD009749.pub2","DOI":"10.1002\/14651858.CD009749.pub2"},{"issue":"9","key":"1119_CR48","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.1007\/s10815-013-0018-x","volume":"30","author":"MR Fouany","year":"2013","unstructured":"Fouany MR, Sharara FI. Is there a role for DHEA supplementation in women with diminished ovarian reserve? J Assist Reprod Genet. 2013;30(9):1239\u201344. https:\/\/doi.org\/10.1007\/s10815-013-0018-x","journal-title":"J Assist Reprod Genet"},{"key":"1119_CR49","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1186\/1477-7827-11-44","volume":"11","author":"A Narkwichean","year":"2013","unstructured":"Narkwichean A, Maalouf W, Campbell BK, Jayaprakasan K. Efficacy of dehydroepiandrosterone to improve ovarian response in women with diminished ovarian reserve: a meta-analysis. Reprod Biol Endocrinol. 2013;11:44. https:\/\/doi.org\/10.1186\/1477-7827-11-44","journal-title":"Reprod Biol Endocrinol"},{"issue":"1","key":"1119_CR50","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jgyn.2016.01.002","volume":"46","author":"JC Qin","year":"2017","unstructured":"Qin JC, Fan L, Qin AP. The effect of dehydroepiandrosterone (DHEA) supplementation on women with diminished ovarian reserve (DOR) in IVF cycle: evidence from a meta-analysis. J Gynecol Obstet Hum Reprod. 2017;46(1):1\u20137. https:\/\/doi.org\/10.1016\/j.jgyn.2016.01.002","journal-title":"J Gynecol Obstet Hum Reprod"},{"key":"1119_CR51","doi-asserted-by":"publisher","unstructured":"Richardson A, Jayaprakasan K. The Use of Androgen Priming in Women with Reduced Ovarian Reserve Undergoing Assisted Reproductive Technology. Semin Reprod Med. 2021;39(5\u201306):207\u201319. https:\/\/doi.org\/10.1055\/s-0041-1735646","DOI":"10.1055\/s-0041-1735646"},{"issue":"2","key":"1119_CR52","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1093\/humupd\/dmr051","volume":"18","author":"JK Bosdou","year":"2012","unstructured":"Bosdou JK, Venetis CA, Kolibianakis EM, Toulis KA, Goulis DG, Zepiridis L, et al. The use of androgens or androgen-modulating agents in poor responders undergoing in vitro fertilization: a systematic review and meta-analysis. Hum Reprod Update. 2012;18(2):127\u201345. https:\/\/doi.org\/10.1093\/humupd\/dmr051","journal-title":"Hum Reprod Update"},{"issue":"3","key":"1119_CR53","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1093\/humrep\/der464","volume":"27","author":"SK Sunkara","year":"2012","unstructured":"Sunkara SK, Coomarasamy A, Arlt W, Bhattacharya S. Should androgen supplementation be used for poor ovarian response in IVF? Hum Reprod. 2012;27(3):637\u201340. https:\/\/doi.org\/10.1093\/humrep\/der464","journal-title":"Hum Reprod"},{"issue":"8","key":"1119_CR54","doi-asserted-by":"publisher","first-page":"1941","DOI":"10.1093\/humrep\/der150","volume":"26","author":"K Yakin","year":"2011","unstructured":"Yakin K, Urman B. DHEA as a miracle drug in the treatment of poor responders; hype or hope? Hum Reprod. 2011;26(8):1941\u20134. https:\/\/doi.org\/10.1093\/humrep\/der150","journal-title":"Hum Reprod"},{"key":"1119_CR55","doi-asserted-by":"publisher","unstructured":"Gleicher N, Barad DH. Misplaced obsession with prospectively randomized studies. Reprod Biomed Online. 2010;21(4):440\u20133. https:\/\/doi.org\/10.1016\/j.rbmo.2010.06.042","DOI":"10.1016\/j.rbmo.2010.06.042"},{"issue":"3","key":"1119_CR56","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1210\/edrv-6-3-400","volume":"6","author":"EY Adashi","year":"1985","unstructured":"Adashi EY, Resnick CE, D\u2019Ercole AJ, Svoboda ME, Van Wyk JJ. Insulin-like growth factors as intraovarian regulators of granulosa cell growth and function. Endocr Rev. 1985;6(3):400\u201320. https:\/\/doi.org\/10.1210\/edrv-6-3-400","journal-title":"Endocr Rev"},{"issue":"1","key":"1119_CR57","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1095\/biolreprod55.1.152","volume":"55","author":"Y Yoshimura","year":"1996","unstructured":"Yoshimura Y, Ando M, Nagamatsu S, Iwashita M, Adachi T, Sueoka K, et al. Effects of insulin-like growth factor-I on follicle growth, oocyte maturation, and ovarian steroidogenesis and plasminogen activator activity in the rabbit. Biol Reprod. 1996;55(1):152\u201360. https:\/\/doi.org\/10.1095\/biolreprod55.1.152","journal-title":"Biol Reprod"},{"key":"1119_CR58","doi-asserted-by":"publisher","unstructured":"Adams NR, Briegel JR. Multiple effects of an additional growth hormone gene in adult sheep. J Anim Sci. 2005;83(8):1868\u201374. https:\/\/doi.org\/10.2527\/2005.8381868x","DOI":"10.2527\/2005.8381868x"},{"issue":"2","key":"1119_CR59","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1530\/rep-14-0494","volume":"149","author":"BM Weall","year":"2015","unstructured":"Weall BM, Al-Samerria S, Conceicao J, Yovich JL, Almahbobi G. A direct action for GH in improvement of oocyte quality in poor-responder patients. Reproduction. 2015;149(2):147\u201354. https:\/\/doi.org\/10.1530\/rep-14-0494","journal-title":"Reproduction"},{"issue":"1","key":"1119_CR60","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.fertnstert.2020.03.007","volume":"114","author":"M Cozzolino","year":"2020","unstructured":"Cozzolino M, Cecchino GN, Troiano G, Romanelli C. Growth hormone cotreatment for poor responders undergoing in vitro fertilization cycles: a systematic review and meta-analysis. Fertil Steril. 2020;114(1):97\u2013109. https:\/\/doi.org\/10.1016\/j.fertnstert.2020.03.007","journal-title":"Fertil Steril"},{"issue":"1","key":"1119_CR61","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1186\/s12958-020-00632-w","volume":"18","author":"P Yang","year":"2020","unstructured":"Yang P, Wu R, Zhang H. The effect of growth hormone supplementation in poor ovarian responders undergoing IVF or ICSI: a meta-analysis of randomized controlled trials. Reprod Biol Endocrinol. 2020;18(1):76. https:\/\/doi.org\/10.1186\/s12958-020-00632-w","journal-title":"Reprod Biol Endocrinol"},{"key":"1119_CR62","doi-asserted-by":"publisher","unstructured":"Duffy JM, Ahmad G, Mohiyiddeen L, Nardo LG, Watson A. Growth hormone for in vitro fertilization. Cochrane Database Syst Rev. 2010;2010(1):Cd000099. https:\/\/doi.org\/10.1002\/14651858.CD000099.pub3","DOI":"10.1002\/14651858.CD000099.pub3"},{"key":"1119_CR63","doi-asserted-by":"publisher","unstructured":"Sood A, Mohiyiddeen G, Ahmad G, Fitzgerald C, Watson A, Mohiyiddeen L. Growth hormone for in vitro fertilisation (IVF). Cochrane Database Syst Rev. 2021;11(11):Cd000099. https:\/\/doi.org\/10.1002\/14651858.CD000099.pub4","DOI":"10.1002\/14651858.CD000099.pub4"},{"issue":"3","key":"1119_CR64","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1631\/jzus.B1600437","volume":"18","author":"F Qu","year":"2017","unstructured":"Qu F, Li R, Sun W, Lin G, Zhang R, Yang J, et al. Use of electroacupuncture and transcutaneous electrical acupoint stimulation in reproductive medicine: a group consensus. J Zhejiang Univ Sci B. 2017;18(3):186\u201393. https:\/\/doi.org\/10.1631\/jzus.B1600437","journal-title":"J Zhejiang Univ Sci B"},{"issue":"4","key":"1119_CR65","doi-asserted-by":"publisher","first-page":"912","DOI":"10.1016\/j.fertnstert.2011.07.1093","volume":"96","author":"R Zhang","year":"2011","unstructured":"Zhang R, Feng XJ, Guan Q, Cui W, Zheng Y, Sun W, et al. Increase of success rate for women undergoing embryo transfer by transcutaneous electrical acupoint stimulation: a prospective randomized placebo-controlled study. Fertil Steril. 2011;96(4):912\u20136. https:\/\/doi.org\/10.1016\/j.fertnstert.2011.07.1093","journal-title":"Fertil Steril"},{"issue":"1","key":"1119_CR66","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1136\/acupmed-2017-011483","volume":"37","author":"Z Shuai","year":"2019","unstructured":"Shuai Z, Li X, Tang X, Lian F, Sun Z. Transcutaneous electrical acupuncture point stimulation improves pregnancy outcomes in patients with recurrent implantation failure undergoing in vitro fertilisation and embryo transfer: a prospective, randomised trial. Acupunct Med. 2019;37(1):33\u20139. https:\/\/doi.org\/10.1136\/acupmed-2017-011483","journal-title":"Acupunct Med"},{"issue":"12","key":"1119_CR67","doi-asserted-by":"publisher","first-page":"1905","DOI":"10.1111\/jog.12810","volume":"41","author":"Y Zheng","year":"2015","unstructured":"Zheng Y, Feng X, Mi H, Yao Y, Zhao Y, Li J, et al. Effects of transcutaneous electrical acupoint stimulation on ovarian reserve of patients with diminished ovarian reserve in in vitro fertilization and embryo transfer cycles. J Obstet Gynaecol Res. 2015;41(12):1905\u201311. https:\/\/doi.org\/10.1111\/jog.12810","journal-title":"J Obstet Gynaecol Res"},{"issue":"1","key":"1119_CR68","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1136\/acupmed-2014-010572","volume":"33","author":"Z Shuai","year":"2015","unstructured":"Shuai Z, Lian F, Li P, Yang W. Effect of transcutaneous electrical acupuncture point stimulation on endometrial receptivity in women undergoing frozen-thawed embryo transfer: a single-blind prospective randomised controlled trial. Acupunct Med. 2015;33(1):9\u201315. https:\/\/doi.org\/10.1136\/acupmed-2014-010572","journal-title":"Acupunct Med"},{"issue":"9","key":"1119_CR69","doi-asserted-by":"publisher","first-page":"1842","DOI":"10.1093\/humrep\/deu139","volume":"29","author":"AP Ferraretti","year":"2014","unstructured":"Ferraretti AP, Gianaroli L. The Bologna criteria for the definition of poor ovarian responders: is there a need for revision? Hum Reprod. 2014;29(9):1842\u20135. https:\/\/doi.org\/10.1093\/humrep\/deu139","journal-title":"Hum Reprod"},{"key":"1119_CR70","doi-asserted-by":"publisher","unstructured":"Humaidan P, Alviggi C, Fischer R, Esteves SC. The novel POSEIDON stratification of \u2018Low prognosis patients in Assisted Reproductive Technology\u2019 and its proposed marker of successful outcome. F1000Research. 2016;5:2911. https:\/\/doi.org\/10.12688\/f1000research.10382.1","DOI":"10.12688\/f1000research.10382.1"}],"container-title":["Reproductive Biology and Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12958-023-01119-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12958-023-01119-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12958-023-01119-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,18]],"date-time":"2023-07-18T13:07:00Z","timestamp":1689685620000},"score":1,"resource":{"primary":{"URL":"https:\/\/rbej.biomedcentral.com\/articles\/10.1186\/s12958-023-01119-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,18]]},"references-count":70,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["1119"],"URL":"https:\/\/doi.org\/10.1186\/s12958-023-01119-0","relation":{},"ISSN":["1477-7827"],"issn-type":[{"value":"1477-7827","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,7,18]]},"assertion":[{"value":"7 June 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 July 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 July 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"64"}}